Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 532

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 532
---
 pursuant to SEC rules), TuHURA’s total stockholder return (“TSR”), and TuHURA’s net loss. TuHURA is a “smaller reporting company,” as defined in Rule 12b-2under the Exchange Act, and has elected to provide in this joint proxy statement/prospectus certain scaled disclosures permitted under the Exchange Act for smaller reporting companies. SEC rules require certain adjustments be made to the SCT totals to determine CAP as reported in the pay versus performance table. CAP does not necessarily represent cash and/or equity value transferred to the applicable TuHURA NEOs without restriction, but rather is a valuation calculated under applicable SEC rules. The methodology for calculating CAP as required by Item 402(v) of Regulation S-Ktakes into account, among others, changes in share price and its impact on the fair value of equity awards. For information on TuHURA’s executive compensation program and the approach used by the TuHURA’s compensation committee, please refer to the “TuHURA Executive Compensation” narrative and the outstanding equity awards table. The following table provides information about TuHURA’s principle executive officer (PEO) and non-PEONEOs and certain financial performance information for TuHURA for the reported years.

| Year |     | Summary       
 Compensation  
 Total for     
 Mr. Zarrabian 
 ($)(1)(a)     |         |     | Summary      
 Compensation 
 Total for    
 Dr. Bianco   
 ($)(1)(b)    |           |     | Summary      
 Compensation 
 Total for    
 Mr. Hoffman  
 ($)(1)(c)    |           |     | Compensation  
 actually      
 paid to       
 Mr. Zarrabian 
 ($)           |         |   |     | Compensation  
 actually paid 
 to Dr. Bianco 
 ($)(2)        |           |     | Compensation 
 actually     
 paid to      
 Mr. Hoffman  
 ($)(2)       |           |     | Average      
 Summary      
 Compensation 
 Table Total  
 for non-PEO  
 NEOs ($)(3)  |           |     | Average       
 Summary       
 Compensation  
 actually paid 
 for non-PEO   
 NEOs ($)(2)   |           |   |     | Value of      
 initial fixed 
 $100          
 Investment    
 based on      
 Total         
 Shareholder   
 Return(4)     |       |     | Net        
 Income     
 (Loss)     
 (millions) 
 ($)(5)     |       |   |
| 2024 |     |               |       —